BioSpace News Archive

– Presentation on Tuesday, February 18 th at 11:30 AM ET – BOTHELL, WA, Feb. 11, 2020 (GLOBE NEWSWIRE) -- COCRYSTAL PHARMA, INC. (NASDAQ: COCP) (“Cocrystal” or the “Company”) , a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announced that Dr. Gary Wilcox, Chairman and Chief Executive Officer of Cocrystal, will present at NobleCon16 - Noble Capital Markets’ 16th Annual Investor Conference on Tuesday, February 18, 2020 at 11:30 a.m. ET i

NEW YORK, Feb. 11, 2020 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications, today announced the enrollment of the first patient in an investigator-sponsored clinical trial of its Wilms tumor-1 (WT1)-targeting peptide immunotherapeutic agent, GPS, in combination with Bristol-Myers Squibb’s anti-PD-1 therap

MBI Biopesticides Likely Reduce Greenhouse Gas Emissions 69% to 91% as Compared with Conventional Chemical Pesticide Products

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has signed a Memorandum Of Understanding with RCK Medical Cannabis to develop cannabis chemovars targeted to treat gastro intestinal cancers.

Feb. 11, 2020 13:30 UTC Polaris Partners led financing round for New York City-based start-up Company to focus on the treatment of metastatic cancers through the targeting and exploitation of chromosomal instability NEW YORK--( BUSINESS WIRE )-- Volastra Therapeutics, a biotechnology company developing novel therapies for the treatment of metastatic cancers, launches with a $12 million financing. Polaris Partners led the financing with additional investment from DROI

Feb. 11, 2020 13:30 UTC BELOIT, Wis. & SYDNEY--( BUSINESS WIRE )-- NorthStar Medical Technologies , LLC (NorthStar), a global innovator in the production and distribution of radioisotopes used for medical imaging, and Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, today announced the signing of a Letter of Intent for the commercial supply of copper-67 (Cu-67) as an active pharmaceutical ingredient for Clarity’s pipeline of

Feb. 11, 2020 13:30 UTC -- Zumwalt Also to Serve as Consultant, Bringing Extensive Capital Markets Background to Omeros -- SEATTLE--( BUSINESS WIRE )-- Omeros Corporation (NASDAQ: OMER) today announced the appointment of Kurt Zumwalt, former global treasurer of Amazon.com, Inc., to Omeros’ Board of Directors. He will also serve in a consulting role at Omeros. Mr. Zumwalt brings significant expertise in developing comprehensive business relationships with major banks and fin

Feb. 11, 2020 13:30 UTC WESTLAKE, Ohio--( BUSINESS WIRE )-- Nordson Corporation (Nasdaq:NDSN) today announced that its board of directors declared a second quarter 2020 cash dividend in the amount of $0.38 per common share, payable on March 10, 2020 to shareholders of record as of the close of business on February 25, 2020. This amount equals the $0.38 per common share dividend paid in the first quarter of fiscal year 2020. Nordson Corporation engineers, manufact

Devonian Health Group Inc. announced it has signed an exclusive sales and marketing agreement with SkinSciPac Inc. to market worldwide cosmeceutical products derived from usage of its proprietary R-Spinasome® technology.

Medical Marijuana, Inc. announced that a clinical study conducted in Mexico using its Real Scientific Hemp Oil-X™ cannabidiol oil has been completed and published in the EC Neurology, an internationally peer-reviewed journal that publishes articles related to worldwide research in neuroscience.